{
  "id": 9273888,
  "title": "EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences",
  "url": "https://urgent.news/2026/09/23/eadv-2026-galderma-to-unveil-new-data-advancing-understanding-of-skin",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-23T05:10:10.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/eadv-2026-galderma-to-unveil-new-data-advancing-understanding-of-skin-diseases-skin-longevity-and-real-world-patient-experiences"
  },
  "original_language": "en",
  "account": null,
  "summary": "Galderma will present 19 abstracts, including two oral presentations, at the 2026 EADV Congress, with new data on skin diseases, skin longevity and real-world patient experiences New analyses from the Nemluvio® (nemolizumab) clinical development program will explore long-term data, in line with Galderma’s commitment to improving the outcomes that matter most to patients1-7 Galderma will […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}